NDC 0603-3213 is a in the category. It is labeled and distributed by .
Proprietary Name | NDC 0603-3213 |
Marketing Category | / |
Marketing Category | ANDA |
Application Number | ANDA077749 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-03-31 |
Marketing End Date | 2018-03-31 |
Marketing Category | ANDA |
Application Number | ANDA077749 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-03-31 |
Marketing End Date | 2018-03-31 |
Marketing Category | ANDA |
Application Number | ANDA077749 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2006-03-31 |
Marketing End Date | 2018-03-31 |
Marketing Category | ANDA |
Application Number | ANDA077749 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2006-03-31 |
Marketing End Date | 2018-03-31 |
Marketing Category | ANDA |
Application Number | ANDA077749 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2006-03-31 |
Marketing End Date | 2018-03-31 |
Marketing Category | ANDA |
Application Number | ANDA077749 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-03-31 |
Marketing End Date | 2018-03-31 |
Marketing Category | ANDA |
Application Number | ANDA077749 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-03-31 |
Marketing End Date | 2018-03-31 |